Notably, the AMPKα/MMP9 axis attenuates skeletal muscle fibrosis, while PPAR-γ/NLRP3/NF-κB signaling mitigates pulmonary fibrosis progression (121, 122). Here, PPARG is linked to pulmonary fibrosis.